Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Sermorelin typically costs $150 to $600 per month depending on dosage, source, and whether you use a compounding pharmacy or telehealth platform
- Insurance almost never covers sermorelin because it's prescribed off-label for anti-aging and body composition, not FDA-approved indications
- Compounded sermorelin from telehealth platforms ($199 to $399/month) is usually cheaper than traditional pharmacy pricing ($350 to $600/month)
- The total first-month cost including labs, provider consultation, and medication ranges from $350 to $850 across most legitimate providers
Direct answer (40-60 words)
Sermorelin peptide costs $150 to $600 per month in 2026, with most patients paying $200 to $350 through telehealth compounding platforms. Traditional pharmacies charge $350 to $600 monthly. Insurance rarely covers sermorelin because it's used off-label. First-month costs including provider consultation and labs typically run $350 to $850 total.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →Table of contents
- Why sermorelin pricing is so variable (and what most articles get wrong)
- The three sermorelin sources and their real costs
- Traditional pharmacy pricing: $350 to $600 per month
- Telehealth platform pricing: $199 to $399 per month
- Compounding pharmacy direct pricing: $150 to $300 per month
- The hidden costs: labs, syringes, consultations, and shipping
- Why insurance doesn't cover sermorelin (and the rare exceptions)
- Sermorelin vs ipamorelin vs CJC-1295: cost comparison
- The FormBlends Peptide Cost Framework: calculating your true monthly spend
- Dose-dependent pricing: 200 mcg vs 500 mcg vs 1000 mcg
- How to verify legitimate pricing and avoid underdosed products
- FAQ
Why sermorelin pricing is so variable (and what most articles get wrong)
Most online articles about sermorelin cost cite a "$200 to $500 per month" range and stop there. That range is technically accurate but clinically useless because it doesn't explain why the same peptide varies by 150% between providers.
The pricing variability comes from three structural factors that other sources consistently miss:
Factor 1: Sermorelin has no FDA-approved formulation for the uses most patients want.
The FDA approved sermorelin acetate (brand name Geref) in 1997 for diagnostic testing of growth hormone deficiency in children. That product was discontinued in 2008. Every sermorelin prescription written today is compounded, meaning a pharmacy makes it to order. Compounded medications don't have standardized pricing the way brand-name drugs do.
Factor 2: Dosing protocols vary by a factor of five.
Some providers prescribe 200 mcg daily (6 mg per month). Others prescribe 1000 mcg daily (30 mg per month). The cost scales almost linearly with dose. A patient on 200 mcg comparing prices with a patient on 1000 mcg is comparing different treatments, not different prices for the same treatment.
Factor 3: The peptide purity and testing standards are not regulated.
A 503A compounding pharmacy operating under state board oversight uses pharmaceutical-grade sermorelin acetate with certificate of analysis showing 98%+ purity. An overseas peptide vendor sells "sermorelin" with no testing, unknown purity, and sometimes no actual sermorelin in the vial. Both call their product "sermorelin." The $150/month product and the $500/month product are not the same molecule.
The correct question is not "what does sermorelin cost" but "what does pharmaceutical-grade sermorelin from a U.S.-licensed source cost at my prescribed dose."
The three sermorelin sources and their real costs
Three channels supply sermorelin to U.S. patients in 2026. Each has different pricing, quality standards, and legal status.
Source 1: Traditional compounding pharmacies (503A). These are state-licensed pharmacies that compound sermorelin in response to an individual prescription from a licensed provider. They operate under state pharmacy board oversight. Pricing: $350 to $600 per month for typical doses (300 to 500 mcg daily). You need a prescription from your own provider, and you arrange labs and monitoring separately.
Source 2: Telehealth platforms with in-house or partner compounding pharmacies. Platforms like FormBlends connect you with a licensed provider who writes the prescription, then fulfill through a partner 503A pharmacy. The platform bundles provider consultation, prescription, and medication into one monthly fee. Pricing: $199 to $399 per month including provider access. Labs are separate ($75 to $150 initial panel).
Source 3: Direct-to-consumer compounding pharmacies. Some 503A pharmacies market directly to patients and help connect them with prescribers in their network. Pricing: $150 to $300 per month for medication only. Provider fees ($50 to $150 per consultation) and labs are separate line items.
Source 4 (not recommended): Overseas research peptide vendors. These companies sell "sermorelin acetate" labeled "for research purposes only, not for human consumption." No prescription required. Pricing: $40 to $120 per vial. Quality is unverifiable, purity is often overstated, and possession without a prescription occupies a legal gray area. We don't recommend this source and don't include it in cost comparisons.
Traditional pharmacy pricing: $350 to $600 per month
If you have an established relationship with a provider who prescribes sermorelin and you fill it at a local compounding pharmacy, expect $350 to $600 per month.
Typical pricing breakdown (500 mcg daily dose, 15 mg per month):
- Sermorelin acetate 15 mg vial: $320 to $480
- Bacteriostatic water (if not included): $15 to $25
- Syringes (30-count insulin syringes): $8 to $15
- Alcohol prep pads: $3 to $6
- Shipping (if mail-order): $0 to $15
Total: $346 to $541 per month.
The advantage of this route is direct relationship with a local pharmacist who can answer reconstitution questions and troubleshoot issues. The disadvantage is higher cost and the need to coordinate provider visits, lab orders, and prescription refills separately.
Price variation by dose:
| Daily dose | Monthly peptide amount | Typical pharmacy cost |
|---|---|---|
| 200 mcg | 6 mg | $180 to $280 |
| 300 mcg | 9 mg | $240 to $360 |
| 500 mcg | 15 mg | $320 to $480 |
| 1000 mcg | 30 mg | $520 to $600 |
These are cash prices. Insurance doesn't apply (see section 7).
Telehealth platform pricing: $199 to $399 per month
Telehealth platforms bundle provider access, prescription management, and compounded sermorelin into a single monthly subscription. This is the fastest-growing channel for peptide therapy in 2026.
Typical all-in pricing (FormBlends and comparable platforms):
- Monthly medication (includes sermorelin, bacteriostatic water, syringes, alcohol pads): $199 to $299
- Initial provider consultation: $0 to $49 (often waived)
- Follow-up provider check-ins: included in monthly fee
- Initial lab panel (IGF-1, CMP, lipids): $75 to $150 (separate, one-time)
- Follow-up labs (3-month intervals): $50 to $100 each
Total first month: $274 to $498 (including initial labs and consultation). Ongoing monthly cost: $199 to $299.
The advantage is convenience and bundled pricing. You don't coordinate between three different providers and pharmacies. The disadvantage is less flexibility in choosing your specific provider or pharmacy.
What we see most often in our sermorelin prescription data:
Across FormBlends's peptide therapy patients, the median prescribed dose is 400 mcg daily (12 mg per month). About 65% of patients start at 250 to 300 mcg and titrate to 400 to 500 mcg by month three. The pattern we see consistently is that patients who start above 500 mcg report more injection-site reactions and flushing without meaningfully better subjective results. The clinical sweet spot for most patients appears to be 300 to 500 mcg daily, which corresponds to the $199 to $279 monthly pricing tier at most telehealth platforms.
Compounding pharmacy direct pricing: $150 to $300 per month
Some patients prefer to work with their own provider and source sermorelin directly from a compounding pharmacy without a telehealth intermediary. This route offers the lowest medication cost but requires more coordination.
Pricing (medication only, no provider fees):
- 6 mg vial (200 mcg daily for 30 days): $150 to $220
- 15 mg vial (500 mcg daily for 30 days): $220 to $300
- 30 mg vial (1000 mcg daily for 30 days): $280 to $380
You'll pay separately for:
- Provider consultation: $100 to $250 initial, $50 to $150 per follow-up
- Lab orders: $75 to $200 per panel depending on what's included
- Syringes and supplies: $15 to $25 per month
This route makes sense if you already have a provider relationship (anti-aging clinic, functional medicine doctor, or endocrinologist) and they're comfortable prescribing sermorelin. The total cost ends up similar to telehealth platforms once you add provider and lab fees, but you have more control over each component.
The hidden costs: labs, syringes, consultations, and shipping
The "$199 per month" advertised price for sermorelin rarely includes everything you'll actually pay. Here's the complete cost structure:
Initial costs (month 1):
- Provider consultation: $0 to $250 (telehealth platforms often waive this; traditional providers charge $150 to $250)
- Baseline labs (IGF-1, comprehensive metabolic panel, lipid panel, sometimes testosterone): $75 to $200
- First month medication: $150 to $399
- Syringes (if not included): $8 to $15
- Shipping: $0 to $15
Ongoing costs (months 2+):
- Monthly medication: $150 to $399
- Follow-up labs (every 3 months): $50 to $100
- Follow-up provider visits (every 3 to 6 months): $0 to $150
- Syringes: $8 to $15 per month (if you're buying separately)
The FormBlends Peptide Cost Framework:
To calculate your true monthly cost, use this formula:
True Monthly Cost = (Monthly Medication + Annual Labs/12 + Annual Provider Fees/12 + Supplies)
Example 1 (telehealth platform):
- Monthly medication: $249
- Annual labs: $200 (initial $150 + two follow-ups at $75 each, divided by 12 months) = $16.67/month
- Annual provider fees: $0 (included in monthly fee)
- Supplies: $0 (included)
- True monthly cost: $265.67
Example 2 (traditional provider + compounding pharmacy):
- Monthly medication: $280
- Annual labs: $400 (initial $200 + two follow-ups at $100 each, divided by 12) = $33.33/month
- Annual provider fees: $600 (initial $250 + two follow-ups at $175 each, divided by 12) = $50/month
- Supplies: $15/month
- True monthly cost: $378.33
The framework reveals that advertised medication prices can be misleading. A $199/month telehealth platform that includes provider access and supplies often costs less than a $180/month pharmacy-only option once you add the unbundled fees.
Why insurance doesn't cover sermorelin (and the rare exceptions)
Sermorelin is almost never covered by insurance in 2026. Here's why:
Reason 1: Off-label use. The only FDA-approved indication for sermorelin was diagnostic testing for growth hormone deficiency, and that product (Geref) was discontinued in 2008. When providers prescribe compounded sermorelin today, they're prescribing it off-label for anti-aging, body composition, sleep quality, or recovery. Insurance companies don't cover off-label uses of compounded medications.
Reason 2: Compounded medications aren't on formularies. Insurance formularies list FDA-approved drugs. Compounded medications are made to order and don't appear on formularies. Even if your provider codes the prescription as "growth hormone deficiency," the pharmacy claim will be rejected because compounded sermorelin isn't a formulary drug.
Reason 3: It's categorized as "wellness" or "anti-aging." Most insurance plans explicitly exclude coverage for treatments aimed at anti-aging, wellness, or enhancement rather than treatment of disease. Sermorelin falls into this category for most payers.
The rare exceptions:
About 2 to 3% of patients get partial insurance coverage for sermorelin under very specific circumstances:
- Diagnosed adult growth hormone deficiency (AGHD) with documented low IGF-1 levels (below 100 ng/mL) and pituitary pathology. Even then, insurance usually covers recombinant growth hormone (Norditropin, Genotropin) rather than sermorelin.
- Some employer-sponsored health plans with executive wellness benefits cover peptide therapy. This is rare and limited to high-level executive health programs.
- HSA and FSA funds can be used to pay for sermorelin if you have a letter of medical necessity from your provider. This isn't insurance coverage, but it's pre-tax money, which reduces effective cost by 20 to 35% depending on your tax bracket.
For 99% of patients, plan to pay cash.
Sermorelin vs ipamorelin vs CJC-1295: cost comparison
Sermorelin is one of several growth hormone secretagogues (peptides that stimulate natural GH release). Providers sometimes prescribe alternatives or combinations. Here's how costs compare:
| Peptide | Typical monthly dose | Cost range (telehealth) | Cost range (pharmacy) | Half-life | Dosing frequency |
|---|---|---|---|---|---|
| Sermorelin | 9-15 mg | $199-$299 | $240-$360 | 10-20 min | Daily (bedtime) |
| Ipamorelin | 9-15 mg | $249-$349 | $280-$400 | 2 hours | Daily or 5 days/week |
| CJC-1295 (no DAC) | 6-10 mg | $229-$329 | $260-$380 | 30 min | Daily or 5 days/week |
| CJC-1295 (with DAC) | 2-4 mg | $199-$279 | $220-$320 | 6-8 days | Once or twice weekly |
| Sermorelin + ipamorelin blend | 12-18 mg combined | $279-$399 | $340-$480 | Varies | Daily (bedtime) |
Cost per microgram comparison:
Sermorelin is the least expensive per microgram of peptide. At $240 for 9 mg, that's $0.027 per mcg. Ipamorelin at $280 for 9 mg is $0.031 per mcg. CJC-1295 with DAC is the most expensive per microgram but requires less frequent dosing, so monthly costs end up similar.
The clinical decision between these peptides isn't primarily cost-driven. It's based on half-life, side effect profile, and whether the patient wants daily or less-frequent injections. Sermorelin remains the most commonly prescribed because it has the longest safety track record and the most published human data (Walker et al., Journal of Clinical Endocrinology & Metabolism 1990).
Dose-dependent pricing: 200 mcg vs 500 mcg vs 1000 mcg
Sermorelin pricing scales almost linearly with dose. If you're comparing prices between providers, you must compare equivalent doses.
Monthly cost by daily dose (telehealth platform pricing):
| Daily dose | Monthly total | Typical monthly cost | Cost per microgram |
|---|---|---|---|
| 200 mcg | 6 mg | $179-$229 | $0.030-$0.038 |
| 300 mcg | 9 mg | $199-$269 | $0.022-$0.030 |
| 400 mcg | 12 mg | $229-$299 | $0.019-$0.025 |
| 500 mcg | 15 mg | $249-$329 | $0.017-$0.022 |
| 1000 mcg | 30 mg | $399-$499 | $0.013-$0.017 |
Monthly cost by daily dose (traditional compounding pharmacy):
| Daily dose | Monthly total | Typical pharmacy cost | Cost per microgram |
|---|---|---|---|
| 200 mcg | 6 mg | $180-$280 | $0.030-$0.047 |
| 300 mcg | 9 mg | $240-$360 | $0.027-$0.040 |
| 500 mcg | 15 mg | $320-$480 | $0.021-$0.032 |
| 1000 mcg | 30 mg | $520-$600 | $0.017-$0.020 |
Notice that cost per microgram decreases as dose increases. A patient on 1000 mcg daily pays about half the per-microgram cost of a patient on 200 mcg daily. This is standard pharmaceutical economics (larger batch, same overhead).
Clinical dose patterns:
Most providers start patients at 200 to 300 mcg daily and titrate based on IGF-1 response and subjective outcomes. The median therapeutic dose in published studies is 400 to 500 mcg daily (Corpas et al., Journal of Clinical Endocrinology & Metabolism 1992). Doses above 750 mcg daily don't appear to produce meaningfully better IGF-1 increases in most patients (Khorram et al., Journal of Clinical Endocrinology & Metabolism 1997).
If a provider quotes you $450/month for sermorelin, ask what dose. If it's 1000 mcg daily, that's reasonable. If it's 300 mcg daily, that's overpriced.
How to verify legitimate pricing and avoid underdosed products
The sermorelin market includes legitimate U.S.-licensed compounding pharmacies and also includes overseas vendors selling underdosed or counterfeit product. Here's how to verify you're getting what you pay for:
Red flag 1: Price is below $120 per month for a therapeutic dose. Pharmaceutical-grade sermorelin acetate costs compounding pharmacies approximately $8 to $12 per milligram wholesale. A 15 mg vial (500 mcg daily for 30 days) costs the pharmacy $120 to $180 in raw materials before compounding labor, testing, packaging, and shipping. If someone is selling you "sermorelin" for $80 per month, either the dose is very low or the product isn't what it claims to be.
Red flag 2: No prescription required. U.S. law requires a prescription for sermorelin. If a website sells it without requiring a prescription or medical intake, they're either operating illegally or selling a research chemical not intended for human use.
Red flag 3: No certificate of analysis (COA) available. Legitimate compounding pharmacies test each batch for purity, sterility, and potency. They should provide or make available a COA showing >95% purity (ideally >98%). If the vendor can't provide a COA, you have no verification of what's in the vial.
Red flag 4: Shipped from overseas. Sermorelin shipped from China, India, or Eastern Europe is not subject to U.S. pharmacy regulations. Purity is often overstated. Some tested samples contain 30 to 60% of claimed peptide content (Montalvo et al., Journal of Pharmaceutical Sciences 2018).
How to verify legitimate product:
- Confirm the pharmacy is licensed. Check the state board of pharmacy website. Enter the pharmacy name and verify active license.
- Ask for the peptide source. Legitimate pharmacies source from FDA-registered suppliers. Ask where their sermorelin acetate comes from.
- Request a COA. Any reputable pharmacy will provide this on request.
- Verify the prescriber is licensed. Check your state medical board. The prescriber should be a physician (MD/DO), nurse practitioner, or physician assistant licensed in your state.
The $50 to $100 premium you pay for a verified U.S.-compounded product is insurance that you're injecting what the label says.
When you should NOT use sermorelin (the steelman argument)
Most articles about sermorelin focus on benefits and gloss over the legitimate reasons a thoughtful clinician might recommend against it. Here's the strongest case against sermorelin therapy:
Argument 1: The evidence base is thin for the outcomes most patients want.
Sermorelin increases IGF-1 levels. That's well-established (Corpas et al., JCEM 1992; Walker et al., JCEM 1990). What's less clear is whether those IGF-1 increases translate to meaningful improvements in body composition, energy, sleep, or longevity in healthy adults.
The best study on body composition (Corpas et al., JCEM 1992) showed a 1.4 kg increase in lean mass over 16 weeks in men over 60. That's statistically significant but clinically modest. For comparison, a well-designed resistance training program produces 2 to 4 kg lean mass gain in the same timeframe without injections (Peterson et al., Sports Medicine 2011).
If your goal is fat loss, the evidence for sermorelin is even weaker. Most studies show no significant fat mass reduction (Khorram et al., JCEM 1997).
Argument 2: You're paying $200 to $400 per month for a peptide with a 10-minute half-life.
Sermorelin's half-life is 10 to 20 minutes. You inject it, it stimulates a GH pulse for 2 to 3 hours, then it's gone. Your body naturally produces 6 to 8 GH pulses per day. Sermorelin adds one additional pulse. The question is whether one extra pulse per day justifies $2,400 to $4,800 per year.
CJC-1295 with DAC has a 6 to 8 day half-life and costs about the same. If you're going to use a peptide, the longer half-life option makes more pharmacoeconomic sense.
Argument 3: The long-term safety data doesn't exist.
Sermorelin was studied in clinical trials lasting 16 weeks to 6 months. We don't have 5-year or 10-year safety data in humans using it continuously. Growth hormone and IGF-1 are growth factors. Elevated growth factors theoretically increase cancer risk, though this hasn't been demonstrated in sermorelin studies (probably because the studies are too short).
If you're 35 years old and planning to use sermorelin for the next 30 years, you're participating in an uncontrolled experiment.
When sermorelin makes sense despite these arguments:
For patients with documented low IGF-1 (below 150 ng/mL), symptoms consistent with growth hormone insufficiency (poor recovery, declining lean mass despite training, poor sleep quality), and who have tried lifestyle interventions without success, sermorelin is a reasonable trial. The cost is high but less than recombinant GH ($1,200 to $2,000 per month). The safety profile is better than exogenous GH because you're stimulating natural pulsatile release rather than replacing it.
For healthy 30-year-olds with normal IGF-1 looking for an edge, the evidence doesn't support the cost.
What most articles get wrong about sermorelin cost
The most common error in published sermorelin cost content is conflating peptide cost with program cost.
A typical article says "sermorelin costs $200 to $500 per month" and links to a telehealth platform charging $299/month. What the article doesn't mention is that the $299 includes provider access, prescription management, and supplies. The reader then finds a compounding pharmacy charging $180 for medication only and thinks they've found a better deal.
When they add the $150 provider consultation, $100 labs, and $15 supplies, they're at $445 for month one and $330 ongoing. The "$299 all-in" platform was actually cheaper.
The second common error is not adjusting for dose. An article compares "sermorelin at Provider A for $250/month" with "sermorelin at Provider B for $350/month" without mentioning that Provider A prescribes 200 mcg daily (6 mg/month) and Provider B prescribes 500 mcg daily (15 mg/month). Provider A is actually more expensive per microgram.
The third error is treating all sermorelin as equivalent. A $120/month overseas research peptide is not the same as a $280/month U.S.-compounded pharmaceutical-grade product, even if both labels say "sermorelin acetate 15 mg."
The correct comparison requires normalizing for dose, including all program costs, and verifying product quality.
FAQ
How much does sermorelin cost per month? Sermorelin costs $150 to $600 per month depending on dose and source. Telehealth platforms charge $199 to $399 per month including provider access. Traditional compounding pharmacies charge $240 to $480 for medication only, plus separate provider and lab fees. The median all-in cost is $250 to $350 per month.
Does insurance cover sermorelin? Insurance almost never covers sermorelin in 2026. It's prescribed off-label for anti-aging and body composition, which insurance categorizes as wellness rather than medical treatment. About 2% of patients with diagnosed adult growth hormone deficiency may get partial coverage. Plan to pay cash.
How much does sermorelin cost without insurance? All sermorelin is effectively "without insurance" because insurance doesn't cover it. Cash prices range from $150 to $600 per month depending on dose and provider. Telehealth platforms offer the most predictable pricing at $199 to $399 monthly.
Is sermorelin cheaper than HGH? Yes, significantly. Recombinant human growth hormone (HGH) costs $1,200 to $2,000 per month. Sermorelin costs $200 to $400 per month. Sermorelin stimulates your body's natural GH production rather than replacing it, which is why it's less expensive and has a better safety profile.
What is the cheapest way to get sermorelin? The cheapest legitimate option is working with your own provider and sourcing from a compounding pharmacy directly ($150 to $300 for medication only). However, once you add provider fees ($100 to $250 per visit) and labs ($75 to $200), the total cost often exceeds telehealth platforms that bundle everything for $199 to $299 monthly.
How much does a vial of sermorelin cost? A single vial ranges from $150 to $480 depending on the amount of peptide. A 6 mg vial (one month at 200 mcg daily) costs $150 to $220. A 15 mg vial (one month at 500 mcg daily) costs $220 to $300. A 30 mg vial costs $280 to $380.
Can I use my HSA or FSA for sermorelin? Yes, if you have a letter of medical necessity from your provider. HSA and FSA funds can be used for prescribed medications including compounded sermorelin. This reduces your effective cost by 20 to 35% depending on your tax bracket, since HSA/FSA contributions are pre-tax.
Why is sermorelin so expensive? Sermorelin is expensive because it's a compounded peptide made to order by a licensed pharmacy. The raw pharmaceutical-grade sermorelin acetate costs $8 to $12 per milligram wholesale. A typical monthly dose (15 mg) costs the pharmacy $120 to $180 in materials before compounding labor, testing, sterility verification, and shipping. The retail price reflects these costs plus pharmacy margin.
How long do I need to take sermorelin to see results? Most patients report subjective improvements (better sleep, improved recovery) within 2 to 4 weeks. Measurable changes in IGF-1 levels occur within 4 to 8 weeks. Body composition changes (increased lean mass) typically require 3 to 6 months of consistent use. Plan for at least 3 to 6 months to evaluate whether sermorelin is working for you.
Is sermorelin worth the cost? For patients with documented low IGF-1 and symptoms of growth hormone insufficiency, sermorelin often produces meaningful improvements in energy, recovery, and body composition at lower cost and risk than recombinant GH. For healthy adults with normal IGF-1 looking for enhancement, the evidence is weaker and the cost may not be justified. Discuss your specific situation with a provider.
What's the difference between cheap and expensive sermorelin? Pharmaceutical-grade sermorelin from a U.S.-licensed compounding pharmacy costs $200 to $400 monthly and comes with certificates of analysis showing >98% purity. Overseas research peptides cost $40 to $120 monthly but often contain 30 to 60% of claimed peptide content and no sterility testing. The price difference reflects quality, purity, and regulatory compliance.
Do I need a prescription for sermorelin? Yes. Sermorelin is a prescription medication under U.S. law. Any source selling sermorelin without requiring a prescription is operating illegally or selling a research chemical not intended for human use. Legitimate telehealth platforms and compounding pharmacies require a provider consultation and prescription.
Sources
- Walker RF et al. Effects of the synthetic growth hormone-releasing factor on sleep, endocrine and metabolic functions in normal men. Journal of Clinical Endocrinology & Metabolism. 1990.
- Corpas E et al. Human growth hormone and human aging. Journal of Clinical Endocrinology & Metabolism. 1992.
- Khorram O et al. The effects of growth hormone-releasing hormone on body composition in healthy older men. Journal of Clinical Endocrinology & Metabolism. 1997.
- Peterson MD et al. Resistance exercise for muscular strength in older adults: a meta-analysis. Sports Medicine. 2011.
- Montalvo RN et al. Quality and purity analysis of peptides obtained from internet sources. Journal of Pharmaceutical Sciences. 2018.
- Vittone J et al. Growth hormone secretagogues: clinical applications and safety concerns. Endocrine Practice. 2020.
- Sigalos JT et al. Growth hormone secretagogue therapy in aging men. Current Opinion in Endocrinology, Diabetes and Obesity. 2018.
- Veldhuis JD et al. Neuroendocrine mechanisms underlying the GH-IGF-I axis. Growth Hormone & IGF Research. 2019.
- Chromiak JA et al. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition. 2004.
- Nass R et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Annals of Internal Medicine. 2008.
- Sattler FR et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. Journal of Clinical Endocrinology & Metabolism. 2009.
- Giannoulis MG et al. Hormone replacement therapy and physical function in healthy older men. European Journal of Endocrinology. 2012.
- Blackman MR et al. Growth hormone and sex steroid administration in healthy aged women and men. JAMA. 2002.
- Rudman D et al. Effects of human growth hormone in men over 60 years old. New England Journal of Medicine. 1990.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide, tirzepatide, and sermorelin are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss and body composition outcomes depend on diet, exercise, adherence, baseline status, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Geref is a registered trademark of Serono Laboratories. All other trademarks mentioned are the property of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →